Stock listing
IBX Stock Price, News, Filings & Events — Imagion Biosystems Ltd.
Selected listing: IBX · ASX · AUD · AU
This page tracks Imagion Biosystems Ltd.'s IBX:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IBX:ASX. IBX:ASX is the stock-level entry point for investors researching Imagion Biosystems Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Imagion Biosystems Ltd. (Ticker: IBX) is a public company based in Australia, focused on developing innovative medical imaging technologies. With a market capitalization of approximately AUD 4.89 million, the company aims to advance its proprietary imaging platform for improved healthcare outcomes.

- Ticker
- IBX:ASX
- Asset type
- Stock
- Market cap
- $4.6M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
Imagion Biosystems Ltd. IBX:ASX stock context
This page tracks Imagion Biosystems Ltd.'s IBX:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IBX:ASX. IBX:ASX is the stock-level entry point for investors researching Imagion Biosystems Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Imagion Biosystems Ltd. (Ticker: IBX) is a public company based in Australia, focused on developing innovative medical imaging technologies. With a market capitalization of approximately AUD 4.89 million, the company aims to advance its proprietary imaging platform for improved healthcare outcomes.
Latest news from Imagion Biosystems Ltd.
Imagion Resumes MagSense® Nanoparticle Manufacturing Capabilities
September 14, 2026
IBX Phase 2 Clinical Trial Update
August 25, 2026
Appendix 4C and Quarterly Activities Report - June 2026
July 30, 2026
Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial
June 25, 2026
IBX Secures Firm Commitments for $3.75m for Clinical Trial
June 24, 2026
Research Imagion Biosystems Ltd.
Imagion Biosystems Ltd. investor report
Review AI stock analysis and investor report context for IBX:ASX.
Imagion Biosystems Ltd. company profile
View the public company page for Imagion Biosystems Ltd. on 6ix.
Imagion Biosystems Ltd. news
Read company news and market updates connected to Imagion Biosystems Ltd..
Imagion Biosystems Ltd. investor events
Find investor webinars, events, and replay context for Imagion Biosystems Ltd..